About Curadev Pharma Private Limited
Data last updated:
Curadev Pharma Private Limited is a private limited company based in New, Delhi, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 07 January 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33111DL2010PTC197755. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹2.5 Cr and a paid-up capital of ₹1.26 Cr. It is led by directors including Arjun Surya and Manish Tandon.
Its last annual general meeting (AGM) was held on 30 December 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H – 3/63 First Floor Vikaspuri, New, Delhi, India – 110018.
As per the financials filed for FY 2025, the company reported a revenue of ₹14.08 Cr, a growth of 24% compared to the previous year. For the same year it recorded a net loss of ₹20.46 Cr (net margin -145.4%) and EBITDA of -₹19.14 Cr (EBITDA margin -136%). Revenue has declined at a compounded annual rate (CAGR) of 26% over three years and 38% over five years.
The company has about 46 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Curadev Pharma. As per MCA filings, the company has satisfied charges of ₹41 Cr on record. Court records list 2 cases involving the company, including 1 filed by the company and 1 filed against it. The company has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹5 Cr; the latest was in September 2016.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website curadev.in.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressH – 3/63 First Floor Vikaspuri, New, Delhi, India – 110018
- IndustryPharma, Pharma Contract R&D
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Curadev Pharma Private Limited FY 2025 filings available
Curadev Pharma Private Limited reported revenue of ₹14.08 Cr (up 24% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Curadev Pharma Private Limited
Revenue rose 24% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 38%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Curadev Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹14.08 Cr | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹19.14 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹20.46 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Curadev Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -136% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -145.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Curadev Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Curadev Pharma Private Limited
Curadev Pharma Private Limited is audited by B S R & Co. LLP for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| B S R & Co. LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Curadev Pharma Private Limited
Curadev Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arjun Surya Also directs: Curadev Immunology LLP, Curadev Therapeutics Up Private Limited | Director | 07 Jan 2010 | 16 Years 9 Months | Current |
| Manish Tandon Also directs: Curadev Immunology LLP, Curadev Therapeutics Up Private Limited | Director | 07 Jan 2010 | 16 Years 9 Months | Current |
| Sandeep Gupta | Director | 03 Feb 2014 | 12 Years 8 Months | Current |
Ownership and Shareholding of Curadev Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Curadev Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Feb 2021 | Hdfc Bank Limited | ₹25 Cr | Satisfied |
| 24 Apr 2017 | Hdfc Bank Limited | ₹10 Cr | Satisfied |
| 25 Mar 2011 | Icici Bank Limited | ₹6 Cr | Satisfied |
Total charge records: 3 View all charges
Deals & Funding of Curadev Pharma Private Limited
Curadev Pharma Private Limited has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹5 Cr; the latest was in September 2016.
Deals on record (1 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2016 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: Startup Incubation and Innovation Centre- IIT Kanpur, an individual |
Full deal history
All 2 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Curadev Pharma Private Limited
Curadev Pharma Private Limited has 2 court cases on record: 1 filed by Curadev Pharma, 1 filed against it. All cases are disposed. Status as checked between 28 Sep 2026 and 30 Sep 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 1 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Writ petition | Filed by the company against an individual | Disposed |
| Allahabad High Court | Tax appeal | Filed against the company by Commissioner of Central Excise | Disposed |
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Curadev Pharma Private Limited
Curadev Pharma operates one associated brand: Curadev Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Small molecule immunotherapy drugs for cancer and inflammation are developed. | curadev.in |
Employees and EPFO Compliance at Curadev Pharma Private Limited
Curadev Pharma Private Limited has a workforce of 46 employees as of Apr 03, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Curadev Pharma Private Limited
Curadev Pharma Private Limited has 3 board changes on record since 2010: 3 appointments. The latest: Sandeep Gupta was appointed as Director on 03 Feb 2014.
Credit Ratings, Litigation & Regulatory Alerts for Curadev Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Curadev Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Curadev Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Curadev Pharma Private Limited
Curadev Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Curadev Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Curadev Pharma Private Limited
Curadev Pharma is an active private limited company based in New, Delhi, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 07 January 2010 (16+ years old) and is registered under CIN U33111DL2010PTC197755.
Curadev Pharma reported revenue of ₹14.08 Cr for FY 2025 (up 24% YoY).
Curadev Pharma has 3 current directors:
- Arjun Surya - Director
- Manish Tandon - Director
- Sandeep Gupta - Director
Curadev Pharma reported a net loss of ₹20.46 Cr (net margin -145.4%) and EBITDA of -₹19.14 Cr (EBITDA margin -136%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Curadev Pharma is -26% over three years and -38% over five years. In the latest year (FY 2025) revenue rose 24%. CAGR is the steady yearly rate that links the first and the last year.
No. Curadev Pharma has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Curadev Pharma is U33111DL2010PTC197755. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Curadev Pharma has 2 court cases on record: 1 filed by the company and 1 filed against it.
Curadev Pharma was incorporated on 07 January 2010, making it 16+ years old. It is registered with the Registrar of Companies, Delhi.
Curadev Pharma has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹5 Cr; the latest was in September 2016.